Simtuzumab
Simtuzumab is a monoclonal antibody against lysyl oxidase-like protein 2 (LOXL2) . Simtuzumab can be used to treat primary sclerosing cholangitis (PSC) and is not effective in patients with bridging fibrosis or compensatory cirrhosis caused by non-alcoholic steatohepatitis.
Product Specifications
CAS Number
1318075-13-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Monoamine Oxidase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
G8135-02C-ML750 100 µL
Glutathione S-Transferase (GST) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
